Matthew H. Carabasi, M.D., a specialist in bone marrow transplantation, is an associate professor of medicine in the Division of Medical Oncology in the Department of Medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia. He is also clinical director of the Bone Marrow Transplant Program at Thomas Jefferson University Hospital and the Kimmel Cancer Center at Jefferson.
Dr. Carabasi has a clinical focus on the development of new strategies to improve patient outcomes after allogeneic stem cell transplantation. The latter entails using certain types of cells known as hematopoietic stem cells from other individuals to help restore the blood-forming system of the bone marrow and the body’s immune system, which is severely damaged by chemotherapy and radiation in treatments for cancers such as leukemias, lymphomas and multiple myeloma.
Prior to joining Jefferson, Dr. Carabasi served as associate professor of medicine from 2000 to 2005 at the University of Southern California’s Keck School of Medicine, where he was also director of the Allogeneic Stem Cell Transplant Service at the Norris Comprehensive Cancer Center. From 1993 to 2000 he served as associate and assistant professor, respectively, in the Department of Medicine at the University of Alabama at Birmingham, and director of the school’s Leukemia Studies Bone Marrow Transplantation Program. He was also an attending physician at Memorial Sloan-Kettering Cancer Center in New York from 1989 to 1993, and an instructor in medicine at Hahnemann Medical College in Philadelphia from 1983 to 1985. Dr. Carabasi is a member of the American College of Physicians, American Society of Clinical Oncology, American Society of Blood and Marrow Transplantation and the American Society of Hematology.
A member of numerous professional and academic committees, Dr. Carabasi is active on the International Bone Marrow Registry’s Chronic Myelogenous Leukemia Working Committee, GVHD/GVL/Immune Reconstitution Working Committee, and the Histocompatibility, Alternative Donors and Stem Cell Sources Working Group Committee. He sits on the editorial board of the journal Bone Marrow Transplantation and is a member of the National Cancer Institute’s Physician Database Query Oncology External Advisory Board.
He has lectured internationally, and has written abstracts, book chapters, and peer reviewed articles in such journals as the New England Journal of Medicine and Blood.
Dr. Carabasi completed a hematology and medical oncology fellowship, as well as a research fellowship at Memorial Sloan-Kettering Cancer Center in 1989. He completed his internship and residency in internal medicine at Hahnemann Medical College and Hospital in 1984, where he also served as chief resident in the Department of Medicine.
A Jefferson alumnus, Dr. Carabasi received a doctor of medicine degree from Jefferson Medical College in 1980. He received a bachelor of arts degree in biology from Princeton University in 1974.